Lina Alekseevna Perekhoda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Lina Alekseevna Perekhoda has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Hanna Yeromina
National University of Pharmacy
3 shared publications - Irina Sych
National University of Pharmacy, Ukraine
2 shared publications L. O. Grinevich
National University of Pharmacy
2 shared publications- Zinaida Ieromina
National University of Pharmacy
2 shared publications A. V. Zhuravel
National University of Pharmacy
1 shared publication- Anatolii Demchenko
Department of Chemistry and Pharmacy, Nizhyn Mykola Gogol State University, 16600 Nizhyn, Ukraine
1 shared publication
Latest Publications
- Open Access
- 1 June 2019
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 380-385
LC-MS/MS METHOD DEVELOPMENT AND VALIDATION FOR THE DETERMINATION OF CARDIAZOL IN HUMAN PLASMA
Objective: The main purpose of this study was to develop a simple, precise, rapid and accurate method for the quantification of cardiazol in human plasma. Methods: Chromatography was achieved on Discovery C18, 50 × 2.1 mm, 5 μm column. Samples were chromatographed in a gradient mode (eluent A (acetonitrile-water–formic acid, 5: 95: 0.1 v/v), eluent B (acetonitrile–formic acid, 100: 0.1 v/v)). The initial content of the eluent B of 8%, which increases linearly to 1.0 min to 100%, is maintained up to 1.5 min and returned to the original 8% to 1.51 min. The mobile phase was delivered at a flow rate of 0.400 ml/min into the mass spectrometer ESI chamber. The sample volume was 300 μl. Results: The total chromatographic run time was 2.5 min and the elution of cardiazol and IS (difenoconazole) occurred at ~2.15 and 1.98 min, respectively. A linear response function was established at 1-100 ng/ml for cardiazol and difenoconazole in human plasma. The % mean recovery for cardiazol in LQC, MQC and HQC was 102.8 %, 100.3 % and 95.9 %. The lowest concentration with the RSD
- 1 June 2019
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 380-385
Open AccessLC-MS/MS METHOD DEVELOPMENT AND VALIDATION FOR THE DETERMINATION OF CARDIAZOL IN HUMAN PLASMA
Objective: The main purpose of this study was to develop a simple, precise, rapid and accurate method for the quantification of cardiazol in human plasma. Methods: Chromatography was achieved on Discovery C18, 50 × 2.1 mm, 5 μm column. Samples were chromatographed in a gradient mode (eluent A (acetonitrile-water–formic acid, 5: 95: 0.1 v/v), eluent B (acetonitrile–formic acid, 100: 0.1 v/v)). The initial content of the eluent B of 8%, which increases linearly to 1.0 min to 100%, is maintained up to 1.5 min and returned to the original 8% to 1.51 min. The mobile phase was delivered at a flow rate of 0.400 ml/min into the mass spectrometer ESI chamber. The sample volume was 300 μl. Results: The total chromatographic run time was 2.5 min and the elution of cardiazol and IS (difenoconazole) occurred at ~2.15 and 1.98 min, respectively. A linear response function was established at 1-100 ng/ml for cardiazol and difenoconazole in human plasma. The % mean recovery for cardiazol in LQC, MQC and HQC was 102.8 %, 100.3 % and 95.9 %. The lowest concentration with the RSD
- Open Access
- 13 March 2019
- Published by National University of Pharmacy in Journal of Organic and Pharmaceutical Chemistry
- Vol. 17 (1(65)) , 58-62
The search for substances with the antimicrobial activity among morpholine-containing 2-R-phenyliminothiazole derivatives
The search for substances with the antimicrobial activity among morpholine-containing 2-R-phenyliminothiazole derivatives
- 13 March 2019
- Published by National University of Pharmacy in Journal of Organic and Pharmaceutical Chemistry
- Vol. 17 (1(65)) , 58-62
Open AccessThe search for substances with the antimicrobial activity among morpholine-containing 2-R-phenyliminothiazole derivatives
The search for substances with the antimicrobial activity among morpholine-containing 2-R-phenyliminothiazole derivatives
- 1 January 2019
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 12 (10) , 4889
The use of the docking studies with the purpose of searching Potential Antihypertensive Drugs
- 1 January 2019
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 12 (10) , 4889
The use of the docking studies with the purpose of searching Potential Antihypertensive Drugs
- Open Access
- 14 August 2018
- Published by The State Expert Center of the Ministry of Health of Ukraine in Farmatsevtychnyi zhurnal
- No. 1,p. 67-73
Synthesis and anаlgеsic properties of (3-allyl-4-aryl-3H-thiazol-2-ylidene)-[4-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-yl)phenyl]amine derivatives
In recent years, attention to itself attracted by the problem of pain treatment, which is due to a noticeable increase in patients, especially the able-bodied age. The aim of the study was to synthesize substances with potentially analgesic properties in the series of hydrobromides (3-allyl-4-aryl-3H-thiazol-2-ylidene)-[4-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-yl)phenyl]amine and to study the effect of the synthesized compounds on the analgesic activity. The objects of the study were (3-allyl-4-aryl-3H-thiazol-2-ylidene)-[4-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-yl)phenyl]amine derivatives, which were synthesized by boiling a thiourea with the corresponding α-haloketones in ethanol medium. Data of NMR 1H spectroscopy were used. The primary evaluation of analgesic activity was carried out on models of thermal («Hot plate») and chemical («Acetic acid cramps») stimulation. A new series of (3-allyl-4-aryl-3H-thiazol-2-ylidene)-[4-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-yl)phenyl]amine derivatives were synthesized and their structure and purity were confirmed by NMR 1H spectroscopy. The analgesic activity of hydrobromide 3-allyl-4-phenyl-3H-thiazol-2-ylidene)-[4-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-yl)phenyl]amine were studied to identify the «structure‒activity» relationship taking into account earlier studies. Screening for analgesic activity for the hydrobromide 3-allyl-4-phenyl-3H-thiazol-2-ylidene)-[4-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-yl)phenyl]-amine were shown that the replacement of the ethyl radical by allyl in the third position of the thiazole ring leads to a decrease in analgesic activity. Moreover, the compound possesses a moderate analgesic effect compared to the reference drug ketorolac.
- 14 August 2018
- Published by The State Expert Center of the Ministry of Health of Ukraine in Farmatsevtychnyi zhurnal
- No. 1,p. 67-73
Open AccessSynthesis and anаlgеsic properties of (3-allyl-4-aryl-3H-thiazol-2-ylidene)-[4-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-yl)phenyl]amine derivatives
In recent years, attention to itself attracted by the problem of pain treatment, which is due to a noticeable increase in patients, especially the able-bodied age. The aim of the study was to synthesize substances with potentially analgesic properties in the series of hydrobromides (3-allyl-4-aryl-3H-thiazol-2-ylidene)-[4-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-yl)phenyl]amine and to study the effect of the synthesized compounds on the analgesic activity. The objects of the study were (3-allyl-4-aryl-3H-thiazol-2-ylidene)-[4-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-yl)phenyl]amine derivatives, which were synthesized by boiling a thiourea with the corresponding α-haloketones in ethanol medium. Data of NMR 1H spectroscopy were used. The primary evaluation of analgesic activity was carried out on models of thermal («Hot plate») and chemical («Acetic acid cramps») stimulation. A new series of (3-allyl-4-aryl-3H-thiazol-2-ylidene)-[4-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-yl)phenyl]amine derivatives were synthesized and their structure and purity were confirmed by NMR 1H spectroscopy. The analgesic activity of hydrobromide 3-allyl-4-phenyl-3H-thiazol-2-ylidene)-[4-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-yl)phenyl]amine were studied to identify the «structure‒activity» relationship taking into account earlier studies. Screening for analgesic activity for the hydrobromide 3-allyl-4-phenyl-3H-thiazol-2-ylidene)-[4-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-yl)phenyl]-amine were shown that the replacement of the ethyl radical by allyl in the third position of the thiazole ring leads to a decrease in analgesic activity. Moreover, the compound possesses a moderate analgesic effect compared to the reference drug ketorolac.
- Open Access
- 11 March 2016
- Published by National University of Pharmacy in News of Pharmacy
- No. 1(85),p. 24-28
The synthesis and physicochemical properties of new derivatives of 5-r-phenylamino-2-mercapto-1,3,4-thiadiazole
With the aim of obtaining new biologically active substances the synthesis of amides of 5-R-phenylamino-1,3,4-thiadiazole-2-yl-thioacetate acid and 5-phenylamino-1,3,4-thiadiazole-2-yl-thio-1-phenon has been conducted. As initial substances 5-R-phenylamino-2-mercapto-1,3,4-thiadiazoles, the corresponding analides of chloracetate acid and chloracetate phenon were used. The reaction of alkylation was conducted in the ethanol medium in the presence of potassium hydroxide. The structure of the compounds synthesized has been confirmed by the method of 1H NMR-spectroscopy. The physicochemical properties and the pharmacological potential of the substances synthesized are discussed. According to the results of calculation methods of prediction of the biological activity (PASSOnline) the probable types of the biological activity of the substances synthesized have been estimated. In compliance with the data of the PASSOnline computer-based prognosis the antineoplastic action (STAT inhibitor of transcription factors) is principally inherent for most compounds of this class.
- 11 March 2016
- Published by National University of Pharmacy in News of Pharmacy
- No. 1(85),p. 24-28
Open AccessThe synthesis and physicochemical properties of new derivatives of 5-r-phenylamino-2-mercapto-1,3,4-thiadiazole
With the aim of obtaining new biologically active substances the synthesis of amides of 5-R-phenylamino-1,3,4-thiadiazole-2-yl-thioacetate acid and 5-phenylamino-1,3,4-thiadiazole-2-yl-thio-1-phenon has been conducted. As initial substances 5-R-phenylamino-2-mercapto-1,3,4-thiadiazoles, the corresponding analides of chloracetate acid and chloracetate phenon were used. The reaction of alkylation was conducted in the ethanol medium in the presence of potassium hydroxide. The structure of the compounds synthesized has been confirmed by the method of 1H NMR-spectroscopy. The physicochemical properties and the pharmacological potential of the substances synthesized are discussed. According to the results of calculation methods of prediction of the biological activity (PASSOnline) the probable types of the biological activity of the substances synthesized have been estimated. In compliance with the data of the PASSOnline computer-based prognosis the antineoplastic action (STAT inhibitor of transcription factors) is principally inherent for most compounds of this class.
- 24 November 2015
- Published by Medical University Prof. Dr. Paraskev Stoyanov - Varna in Scripta Scientifica Pharmaceutica
- Vol. 2 (2) , 53
Synthesis of 5-substituted 1,3,4-thiadiazol-2-yl-sulfanyl¬acetic acid derivatives
- 24 November 2015
- Published by Medical University Prof. Dr. Paraskev Stoyanov - Varna in Scripta Scientifica Pharmaceutica
- Vol. 2 (2) , 53
Synthesis of 5-substituted 1,3,4-thiadiazol-2-yl-sulfanyl¬acetic acid derivatives
- Open Access
- 11 June 2015
- Published by National University of Pharmacy in News of Pharmacy
- No. 2(82),p. 7-11
Physicochemical parameters and the diuretic activity of 5-(4-R)behzyl-1,3,4-oxadiazol-2-il-thioacetic acid amides
The group of aryl(heteryl)amides of 5-(4-R)benzyl-1,3,4-oxadіazol-2-il-thioacetic acid has been tested for compliance with the “drug likeness” concept. A number of physical and chemical properties that determine bioavailability according to Lipinski’s Rule of Five has been calculated using the ACD/ Labs computer programme. It has been found that these compounds can be recommended for further research as compounds with favourable physicochemical properties according to Lipinski’s Rule of Five. The results of the experimental study of the ability of new substances to stimulate the urinary renal function predicted by the computer PASS programme have shown that some of the new compounds synthesized are promising diuretics. The results of studying cytotoxicity in vitro for the most promising compounds have shown that these compounds possess low toxicity. The pharmacological screening has allowed to select two promising compounds that are relevant for further study.
- 11 June 2015
- Published by National University of Pharmacy in News of Pharmacy
- No. 2(82),p. 7-11
Open AccessPhysicochemical parameters and the diuretic activity of 5-(4-R)behzyl-1,3,4-oxadiazol-2-il-thioacetic acid amides
The group of aryl(heteryl)amides of 5-(4-R)benzyl-1,3,4-oxadіazol-2-il-thioacetic acid has been tested for compliance with the “drug likeness” concept. A number of physical and chemical properties that determine bioavailability according to Lipinski’s Rule of Five has been calculated using the ACD/ Labs computer programme. It has been found that these compounds can be recommended for further research as compounds with favourable physicochemical properties according to Lipinski’s Rule of Five. The results of the experimental study of the ability of new substances to stimulate the urinary renal function predicted by the computer PASS programme have shown that some of the new compounds synthesized are promising diuretics. The results of studying cytotoxicity in vitro for the most promising compounds have shown that these compounds possess low toxicity. The pharmacological screening has allowed to select two promising compounds that are relevant for further study.
- 19 November 2002
- Published by Wiley in ChemInform
- Vol. 33 (46) , 90
Michael Addition of N,N′‐Dibenzylmalonamide to N‐Aryl(alkyl)crotonamides.
- 19 November 2002
- Published by Wiley in ChemInform
- Vol. 33 (46) , 90
Michael Addition of N,N′‐Dibenzylmalonamide to N‐Aryl(alkyl)crotonamides.